Literature DB >> 14843112

X-ray and solubility studies of the haemoglobin of sickle-cell anaemia patients.

R R PERUTZ, A M LIQUORI, F EIRICH.   

Abstract

Entities:  

Keywords:  ANEMIA, SICKLE CELL; HEMOGLOBIN AND COMPOUNDS

Mesh:

Substances:

Year:  1951        PMID: 14843112     DOI: 10.1038/167929a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  32 in total

1.  A critical review of human haemoglobin variants. II. Individual haemoglobins.

Authors:  G H BEAVEN; W B GRATZER
Journal:  J Clin Pathol       Date:  1959-03       Impact factor: 3.411

2.  Sulphydryl groups in haemoglobins.

Authors:  V M INGRAM
Journal:  Biochem J       Date:  1955-04       Impact factor: 3.857

3.  Sickling phenomenon produced by hypertonic solutions: a possible explanation for the hyposthenuria of sicklemia.

Authors:  P E PERILLIE; F H EPSTEIN
Journal:  J Clin Invest       Date:  1963-04       Impact factor: 14.808

4.  The SH-group content of human foetal and sickle-cell haemoglobins.

Authors:  A C ALLISON; R CECIL; N S SNOW
Journal:  Biochem J       Date:  1960-02       Impact factor: 3.857

5.  [Electron microscopy studies on internal structure of anucleated erythrocytes. II. Findings in a case of sickle cell anemia].

Authors:  C WOLPERS
Journal:  Klin Wochenschr       Date:  1957-01-15

6.  The sulphydryl groups of sickle-cell haemoglobin.

Authors:  V M INGRAM
Journal:  Biochem J       Date:  1957-04       Impact factor: 3.857

7.  Properties of sickle-cell haemoglobin.

Authors:  A C ALLISON
Journal:  Biochem J       Date:  1957-02       Impact factor: 3.857

8.  [Abnormal human hemoglobin].

Authors:  K BETKE
Journal:  Klin Wochenschr       Date:  1956-02-01

9.  The hereditary anemias.

Authors:  R J WATSON
Journal:  Bull N Y Acad Med       Date:  1954-02

10.  Sickle-cell anemia hemoglobin: the molecular biology of the first "molecular disease"--the crucial importance of serendipity.

Authors:  Vernon M Ingram
Journal:  Genetics       Date:  2004-05       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.